1 Introduction to Research & Analysis Reports
1.1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Overall Market Size
2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size: 2022 VS 2029
2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Aneurysmal Subarachnoid Hemorrhage Drugs Players in Global Market
3.2 Top Global Aneurysmal Subarachnoid Hemorrhage Drugs Companies Ranked by Revenue
3.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Companies
3.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Companies
3.5 Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Aneurysmal Subarachnoid Hemorrhage Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Drugs Players in Global Market
3.8.1 List of Global Tier 1 Aneurysmal Subarachnoid Hemorrhage Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Aneurysmal Subarachnoid Hemorrhage Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Markets, 2022 & 2029
4.1.2 Opioid Analgesic
4.1.3 Calcium Channel Blocker
4.1.4 Anticonvulsant
4.1.5 Stool Softener
4.1.6 Osmotic Agent
4.1.7 Other Drugs
4.2 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue & Forecasts
4.2.1 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2023
4.2.2 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2024-2029
4.2.3 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales & Forecasts
4.3.1 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2023
4.3.2 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2024-2029
4.3.3 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue & Forecasts
5.2.1 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2023
5.2.2 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2024-2029
5.2.3 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales & Forecasts
5.3.1 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2023
5.3.2 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2024-2029
5.3.3 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2022 & 2029
6.2 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue & Forecasts
6.2.1 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2023
6.2.2 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2024-2029
6.2.3 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales & Forecasts
6.3.1 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2023
6.3.2 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2024-2029
6.3.3 By Region – Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.4.2 By Country – North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.4.3 US Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.4.4 Canada Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.4.5 Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.5.3 Germany Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.4 France Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.5 U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.6 Italy Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.7 Russia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.5.9 Benelux Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.6.3 China Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.4 Japan Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.5 South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.6.7 India Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.7.2 By Country – South America Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.7.3 Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.7.4 Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales, 2018-2029
6.8.3 Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8.4 Israel Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
6.8.6 UAE Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Arbor Pharmaceuticals
7.1.1 Arbor Pharmaceuticals Company Summary
7.1.2 Arbor Pharmaceuticals Business Overview
7.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Arbor Pharmaceuticals Key News & Latest Developments
7.2 PDS Biotechnology Corporation
7.2.1 PDS Biotechnology Corporation Company Summary
7.2.2 PDS Biotechnology Corporation Business Overview
7.2.3 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.2.4 PDS Biotechnology Corporation Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.2.5 PDS Biotechnology Corporation Key News & Latest Developments
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Summary
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.3.4 Johnson and Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson and Johnson Key News & Latest Developments
7.4 Mylan N.V
7.4.1 Mylan N.V Company Summary
7.4.2 Mylan N.V Business Overview
7.4.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.4.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Mylan N.V Key News & Latest Developments
7.5 Orexo AB
7.5.1 Orexo AB Company Summary
7.5.2 Orexo AB Business Overview
7.5.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.5.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Orexo AB Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Purdue Pharma
7.7.1 Purdue Pharma Company Summary
7.7.2 Purdue Pharma Business Overview
7.7.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.7.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Purdue Pharma Key News & Latest Developments
7.8 Pharmaxis
7.8.1 Pharmaxis Company Summary
7.8.2 Pharmaxis Business Overview
7.8.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.8.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pharmaxis Key News & Latest Developments
7.9 Sun Pharmaceutical Industries
7.9.1 Sun Pharmaceutical Industries Company Summary
7.9.2 Sun Pharmaceutical Industries Business Overview
7.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Key News & Latest Developments
8 Global Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity, Analysis
8.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity, 2018-2029
8.2 Aneurysmal Subarachnoid Hemorrhage Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Aneurysmal Subarachnoid Hemorrhage Drugs Supply Chain Analysis
10.1 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Value Chain
10.2 Aneurysmal Subarachnoid Hemorrhage Drugs Upstream Market
10.3 Aneurysmal Subarachnoid Hemorrhage Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Aneurysmal Subarachnoid Hemorrhage Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の動脈瘤くも膜下出血治療薬市場予測2023-2029：オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化薬、浸透圧調整薬、その他 |
| 【英語タイトル】Aneurysmal Subarachnoid Hemorrhage Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5651 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：79 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の動脈瘤くも膜下出血治療薬市場規模と予測を収録しています。・世界の動脈瘤くも膜下出血治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の動脈瘤くも膜下出血治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の動脈瘤くも膜下出血治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「オピオイド鎮痛薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 動脈瘤くも膜下出血治療薬のグローバル主要企業は、Arbor Pharmaceuticals、 PDS Biotechnology Corporation、 Johnson and Johnson、 Mylan N.V、 Orexo AB、 Pfizer、 Purdue Pharma、 Pharmaxis、 Sun Pharmaceutical Industries、 Teva Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、動脈瘤くも膜下出血治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の動脈瘤くも膜下出血治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の動脈瘤くも膜下出血治療薬市場：タイプ別市場シェア、2022年 ・オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化薬、浸透圧調整薬、その他 世界の動脈瘤くも膜下出血治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の動脈瘤くも膜下出血治療薬市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の動脈瘤くも膜下出血治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の動脈瘤くも膜下出血治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における動脈瘤くも膜下出血治療薬のグローバル売上、2018年-2023年 ・主要企業における動脈瘤くも膜下出血治療薬のグローバル売上シェア、2022年 ・主要企業における動脈瘤くも膜下出血治療薬のグローバル販売量、2018年-2023年 ・主要企業における動脈瘤くも膜下出血治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Arbor Pharmaceuticals、 PDS Biotechnology Corporation、 Johnson and Johnson、 Mylan N.V、 Orexo AB、 Pfizer、 Purdue Pharma、 Pharmaxis、 Sun Pharmaceutical Industries、 Teva Pharmaceutical ************************************************************* ・調査・分析レポートの概要 動脈瘤くも膜下出血治療薬市場の定義 市場セグメント 世界の動脈瘤くも膜下出血治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の動脈瘤くも膜下出血治療薬市場規模 世界の動脈瘤くも膜下出血治療薬市場規模：2022年 VS 2029年 世界の動脈瘤くも膜下出血治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの動脈瘤くも膜下出血治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の動脈瘤くも膜下出血治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化薬、浸透圧調整薬、その他 動脈瘤くも膜下出血治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 動脈瘤くも膜下出血治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別動脈瘤くも膜下出血治療薬市場規模 2022年と2029年 地域別動脈瘤くも膜下出血治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Arbor Pharmaceuticals、 PDS Biotechnology Corporation、 Johnson and Johnson、 Mylan N.V、 Orexo AB、 Pfizer、 Purdue Pharma、 Pharmaxis、 Sun Pharmaceutical Industries、 Teva Pharmaceutical ... |
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke caused by bleeding in the space surrounding the brain.
This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage Drugs. This report contains market size and forecasts of Aneurysmal Subarachnoid Hemorrhage Drugs in global, including the following market information:
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Aneurysmal Subarachnoid Hemorrhage Drugs companies in 2022 (%)
The global Aneurysmal Subarachnoid Hemorrhage Drugs market was valued at US$ 154.9 million in 2022 and is projected to reach US$ 176.9 million by 2029, at a CAGR of 1.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global aneurysmal subarachnoid hemorrhage drugs market is segmented based on drug class and region. Based on drug class, the market is segmented into opioid analgesic, calcium channel blocker, anticonvulsant, stool softener, osmotic agent/diuretic, and other drugs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, by Type, 2022 (%)
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic Agent
Other Drugs
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs revenues share in global market, 2022 (%)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arbor Pharmaceuticals
PDS Biotechnology Corporation
Johnson and Johnson
Mylan N.V
Orexo AB
Pfizer
Purdue Pharma
Pharmaxis
Sun Pharmaceutical Industries
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aneurysmal Subarachnoid Hemorrhage Drugs, market overview.
Chapter 2: Global Aneurysmal Subarachnoid Hemorrhage Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aneurysmal Subarachnoid Hemorrhage Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Aneurysmal Subarachnoid Hemorrhage Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の動脈瘤くも膜下出血治療薬市場予測2023-2029：オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化薬、浸透圧調整薬、その他] (コード：MMG23JU5651)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の動脈瘤くも膜下出血治療薬市場予測2023-2029：オピオイド鎮痛薬、カルシウムチャネル遮断薬、抗けいれん薬、便軟化薬、浸透圧調整薬、その他]についてメールでお問い合わせ |
